Therma Bright Inc V.THRM

63 Subjects as part of study

[spygate]

The results piece of the news release was positve but the fact that they were only able to secure 63 subjets in all of this time in one of the hardest hit regions in the world is a bit concerning. Add to that that they fell short of the reuirements needed (30 each of positive/negative) participants to submit to FDA/HC for approvals just has me questioning What The heck are they doing down there...perplexing  to say the least and the SP action agrees

[Vb2233]

Initially, I was concerned also. Those numbers are what those agencies FDA/HC require. All is in order. A nr would not be circulated if that was not an industry standard with them. Therma is on it!

[spygate]

I beleive you are missing my point...the concern isnt with the governing bodies requirements...its that Therma in all this time have not been able to secure the required subjects and thus still cannot submit to the regulators...that is the real concern.

[Greenrolls8]

This post has been removed in accordance with Community Policy

[MosaicLamp]

Unfortunately I am agree with spygate. This is a very legit question, thousands of cases everyday and only 63 people tried AcuVid? 

[stockmonster6]

Hello fellow investors, Here's my take - and read the NR very closely. They needed same # of positive as negative cases.  I would suspect as  Brazil is having issues with Covid infections, likely finding the negative cases was hard to do; not finding positive cases. Next point to consider - it isn't about people taking the AcuVid.  Read closer: The RT-PCR results for the